Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 08, 2024
When Gavi, the Vaccine Alliance, was founded in 2001, it logically targeted its support to the poorest countries—with GNI per capita under a pre-defined eligibility threshold—that also had the highest shares of the world’s undervaccinated children. Fast-forward almost 25 years, and the situation has...
Blog Post
April 08, 2024
Gavi is facing several important milestones in 2024: developing its next five-year strategy, known as “Gavi 6.0,” gearing up for its upcoming replenishment, and welcoming its new CEO. This year presents an opportunity for Gavi’s board and leadership to revisit its approach to ensure continued impact...
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
March 18, 2024
Today, Dr. Sania Nishtar assumes her role as Gavi's new CEO. A lot has changed—both within Gavi and in the external environment—since the process began to replace Dr. Seth Berkley, who stepped down last year. Dr. Nishtar’s appointment comes at a critical time for Gavi. As CEO, Dr. Nishtar will play ...
Blog Post
March 08, 2024
For nearly 25 years, innovation has been core to Gavi’s success in accelerating vaccine introductions in lower-income countries. Building on this track record, Gavi has a high-impact opportunity to sharpen its focus on scaling innovations for systems improvement in its next five-year strategic perio...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
Blog Post
December 14, 2023
Harsh fiscal prospects and broader shifts in the health landscape are creating challenges for Gavi’s approach to country eligibility and transition. To date, Gavi’s income-based eligibility model has functioned well during periods of sustained growth in low- and middle-income countries and has helpe...
Blog Post
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...